Acute and chronic effects of seizures in the developing brain: Experimental models

Epilepsia

Volumn 40, Issue SUPPL. 1, 1999, Pages s51-s58

  Jensen, Frances E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Animal models; Epilepsy; Neonate; Perinatal; Status epilepticus

Indexed keywords

GLUTAMATE RECEPTOR; ION CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN DEVELOPMENT; COGNITION; CONFERENCE PAPER; DISEASE PREDISPOSITION; EPILEPTIC STATE; EPILEPTOGENESIS; EXPERIMENTAL MODEL; GABAERGIC SYSTEM; HUMAN; NERVE EXCITABILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0032766159     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00879.x     Document Type: Conference Paper

References (89)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
2. Holmes GL, Lombroso CT. Prognostic value of background patterns in the neonatal EEG. J Clin Neurophysiol 1993;10:323-52.
3. Volpe JJ. Neonatal seizures. Pediatrics 1989;84:422-8.
4. Volpe JJ. Neurology of the newborn. Philadelphia: WB Saunders, 1994.
5. Bergamasco B, Penna P, Ferrero P, Gavinelli R. Neonatal hypoxia and epileptic risk: a clinical prospective study. Epilepsia 1984;25: 131-46.
6. Holmes GL, Kull LL. Neonatal seizures. Am J EEG Technol 1990; 30:281-308.
7. Bernes SM, Kaplan AM. Evolution of neonatal seizures. Pediatr Clin North Am 1994;41:1069-104.
8. Shinnar S. Prolonged febrile seizures and mesial temporal sclerosis. Ann Neurol 1998;43:411-2.
9. Camfield P, Camfield C, Gordon K, Dooley J. What types of epilepsy are preceded by febrile seizures? A population-based study of children. Dev Med Child Neurol 1994;36:887-92.
10. VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998;43:413-26.
11. Rocca WA, Sharbrough FW, Hauser WA, et al. Risk factors for complex-partial seizures: a population-based case control study. Ann Neurol 1987;21:22-31.
12. Dreyfus-Brisac C, Pechanski N, Radvanyi MF, Cukier-Hemeury F, Monod N. Convulsions in neonates. Clinical, electrophysiologic, etiopathogenic and prognostic aspects. Rev Electroencephalogr Neurophysiol Clin 1981;11:367-78.
13. Scher MS, Aso K, Beggarly ME, Hamid MY, Steppe DA, Painter MJ. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics 1993;91:128-34.
14. Bergman I, Painter MJ, Hirsch RP. Outcome in neonates with convulsion treated in an intensive care unit. Ann Neurol 1983;14: 642-7.
15. Reiter PD, Stiles AD. Lorazepam toxicity in a premature infant. Ann Pharmacother 1993;27:727-9.
16. Vlachos P, Kentarchou P, Poulos L, Aloupgiannis G. Lorazepam poisoning. Toxicol Lett 1978;2:109-10.
17. Fox K, Schlaggar BL, Glazewski S, O'Leary DDM. Glutamate receptor blockade at cortical synapses disrupts development of thalamocortical and columnar organization in somatosensory cortex. Proc Natl Acad Sci USA 1996;93:5584-9.
18. Huttenlocher PR, deCourten C, Garey LJ, Van der Loos H. Synaptogenesis in human visual cortex - evidence for synapse elimination during normal development. Neurosci Lett 1982;33:247.
19. Vanier MT, Holm M, Ohman R, Svennerholm L. Developmental profiles of gangliosides in human and rat brain. J Neurochem 1971; 18:581-92.
20. Himwich W. Developmental neurobiology. Springfield, IL: Charles C Thomas, 1970.
21. Mares P, Maresova D, Schickova R. Effect of antiepileptic drugs on metrazol convulsions during ontogenesis in the rat. Physiol Bohem 1981;30:113-21.
22. Romijin HJ, Hofman MA, Gransberger A. At what age is the developing cerebral cortex of the rat comparable to that of the full term newborn baby? Early Hum Dev 1991;26:61-7.
23. Rakic P, Bourgeois JP, Eckenhoff MF, Zecevic N, Goldman-Rakic PS. Concurrent overproduction of synapses in diverse regions of primate cortex. Science 1989;232:232-5.
24. Blanton MG, Loturco JJ, Kriegstein AR. Whole-cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J Neurosci Methods 1989;30:203-10.
25. Flint AC, Liu X, Kriegstein AR. Nonsynaptic glycine receptor activation during early neocortical development. Neuron 1998;20: 43-53.
26. Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa J-L. GABA-A, NMDA, and AMPA receptors: a developmentally regulated "menage a trois." Trends Neurosci 1997;20:523-9.
27. Palacios JM, Niehoff DL, Kuhar MJ. Ontogeny of GABA and benzodiazepine receptors: effects of Triton X-100-bromide and muscimol. Brain Res 1979;179:390-5.
28. Coyle JT, Enna SJ. Neurochemical aspects of the ontogenesis of GABAergic neurons in the rat brain. Brain Res 1976;111:119-33.
29. Swann JW, Brady RJ, Martin DL. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus. Neuroscience 1989;28:551-61.
30. Boulter J, Bettler B, Dingledine R, et al. Molecular biology of the glutamate receptors. Clin Neuropharmacol 1992;15(Suppl 1A):60A-1A.
31. Hollman M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108.
32. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15:41-70.
33. Choi DW. Excitatory cell death. J Neurobiol 1992;23:1261-76.
34. Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology 1994;44(Suppl 8):S14-23.
35. Insel TR, Miller L, Gelhard RE. The ontogeny of excitatory amino acid in the rat forebrain I: N-methyl-d-aspartate and quisqualate receptors. Neuroscience 1990;35:31-43.
36. McDonald JW, Trescher WH, Johnson MV. The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain. Brain Res 1990;526:165-8.
37. Swann JW, Smith KL, Brady RJ. Neural networks and synaptic transmission in immature hippocampus. Adv Exp Med Biol 1990; 268:161-71.
38. Ikonomidou C, Mosinger JL, Shahid Salles K, Labryere J, Olney JW. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N methylaspartate toxicity. J Neurosci 1989;9:2809-18.
39. McDonald JW, Trescher WH, Johnston MV. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res 1992;583:54-70.
40. Wang CD, Jensen FE. NMDA involvement in age-dependent differences in seizure susceptibility in hippocampal slices. Epilepsy Res 1996;23:105-13.
41. Zhong J, Carrozza DP, Williams K, Pritchett DB, Molinoff PB. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem 1995;64:531-9.
42. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994;12:529-40.
43. Fox K. The critical period for long-term in primary sensory cortex. Neuron 1995;15:485-8.
44. Kohr G, Eckhardt S, Luddens H, Monyer H, Seeberg PH. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 1994;12:1031-40.
45. Wenzel A, Villa M, Benke D. Development and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain. J Neurochem 1996;66:1240-8.
46. Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular signaling and cellular consequences. Science 1995;268:239-47.
47. Siesjo BK, Siesjo P. Mechanisms of secondary brain injury. Eur J Anaesthesiol 1996;13:247-68.
48. Owens ED, Sharma D, Corbett M, Jensen FE. Immature hippocampal CA1 pyramidal neurons demonstrate increased AMPA-activated cobalt uptake and lower expression of GluR2 mRNA compared to the adult [Abstract]. Soc Neurosci Abstr 1997;23: 2422.
49. 2+-permeable kainate/AMPA receptors more abundant in immature brain? Neurosci Lett 1992;144:65-9.
50. Pellegrini-Giampietro DE, Bennett MVL, Zukin RS. Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study. Proc Natl Acad Sci USA 1991;88:4157-61.
51. Furuta A, Rothstein JD, Martin LJ. Glutamate transporter subtypes are expressed differentially during rat CNS development. J Neurosci 1997;17:8363-75.
52. Miller HP, Levey AI, Rothstein JD, Tzingounis AV, Conn PJ. Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J Neurochem 1997;68:1564-70.
53. Tanaka K, Watase K, Manabe T, et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997;276:1699-702.
54. Haglund MM, Schwartzkroin PA. Role of NA,K pump potassium regulation and IPSPs in seizures and spreading depression in immature hippocampal slices. J Neurophysiol 1990;63:225-39.
55. Moody WM. The development of voltage-gated ion channels and its relation to activity-dependent developmental events. Curr Top Dev Biol 1998;39:159-85.
56. Wasterlain CG, Massarweh W, Solias A, Rouk E, Sloviter RF. Selective vulnerability of neurons to hypoxia-ischemia: role of calcium-binding protein [Abstract]. Soc Neurosci Abstr 1988;14: 1064.
57. Albala BJ, Moshe SL, Okada R. Kainic-acid seizures: a developmental study. Brain Res 1984;315:139-48.
58. Stafstrom CE, Thompson JL, Holmes GL. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Dev Brain Res 1992;65:227-36.
59. Sperber EF. The relationship between seizures and damage in the maturing brain. Epilepsy Res 1996;S12:365-76.
60. Moshe SL, Albala BJ. Maturational changes in postictal refractoriness and seizure susceptibility in developing rats. Ann Neurol 1983;13:552-7.
61. Holmes GL. Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 1997;38:12-30.
62. Liu Z, Mikati M, Holmes GL. Mesial temporal sclerosis: pathogenesis and significance. Pediatr Neurol 1995;12:516.
63. Thompson K, Holm AM, Schousboue A, Popper P, Micevych P, Wasterlain CG. Hippocampal stimulation produces neuronal death in the immature brain. Neuroscience 1998;82:337-48.
64. Wasterlain CG. Recurrent seizures in the developing brain are harmful. Epilepsia 1997;38:728-34.
65. Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994;263: 1618-23.
66. Kirschner PB, Henshaw R, Weise J, et al. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 1995;15:619-23.
67. A receptor gene expression in adult rat hippocampus: an in situ hybridization study. J Neurosci 1994;14: 2697-707.
68. Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 1991;7:165-76.
69. Parent JM, Lowenstein DH. Mossy fiber reorganization in the epileptic hippocampus. Curr Opin Neurol 1997;10:103-9.
70. Jensen FE, Applegate CD, Holtzman D, Belin T, Burchfiel J. Epileptogenic effects of hypoxia in immature rodent brain. Ann Neurol 1991;29:629-37.
71. Jensen FE, Holmes GH, Lombroso CT, Blume H, Firkusny I. Age dependent long term changes in seizure susceptibility and neurobehavior following hypoxia in the rat. Epilepsia 1992;33:971-80.
72. Jensen FE, Wang C, Stafstrom CE, Liu Z, Geary C, Stevens MC. Acute and chronic increases in excitability in rat hippocampal slices after perinatal hypoxia in vivo. J. Neurophysiol 1998;79:73-81.
73. Jensen FE, Alvarado S, Firkusny IR, Geary C. NBQX blocks the acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 1995;36:966-72.
74. Corbett M, Rio C, Corfas G, Jensen FE. Perinatal hypoxia-induced seizures decrease GluR2 AMPA subunit protein in neocortex [Abstract]. Soc Neurosci Abstr 1997;23:809.
75. Smith KL, Lee CL, Swann JW. Local circuit abnormalities in chronically epileptic rats after intrahippocampal tetanus toxin injection in infancy. J Neurophysiol 1998;79:106-16.
76. Anderson AE, Hrachovy RA, Swann JW. Increased susceptibility to tetanus-induced seizures in immature rats. Epilepsy Res 1997; 26:433-42.
77. Toth Z, Van X-X, Haftoglu S, Ribak C, Baram TZ. Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J Neurosci 1998;18:4285-94.
78. Germano IM, Sperber EF. Transplacentally induced neuronal migration disorders: an animal model for the study of the epilepsies. J Neurosci Res 1998;51:473-88.
79. Baraban SC, Schwartzkroin PA. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy Res 1996;23:189-94.
80. Schwartzkroin PA, Wenzel HJ, Hochman DW, Baraban SC. Characterization of heterotopic cell clusters in an animal model of neuronal migration disorders [Abstract]. Epilepsia 1997;38(Suppl 6):36.
81. Luhmann HJ, Raabe K. Characterization of neuronal migration disorders in neocortical structures: I. Expression of epileptiform activity in an animal model. Epilepsy Res 1996;26:67-74.
82. Jacobs KM, Gutnick MJ, Prince DA. Hyperexcitability in a model of cortical maldevelopment. Cereb Cortex 1996;6:514-23.
83. Mikati MA, Holmes GL, Chronopoulos A, et al. Phenobarbital modifies seizure-induced brain injury in the developing brain. Ann Neurol 1994;36:425-33.
84. Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures - effects on intelligence and on seizure recurrence. N Engl J Med 1990;322:364-9.
85. Diaz J, Schain RJ, Bailey BG. Phenobarbital-induced brain growth retardation in artificially reared rat pups. Biol Neonate 1977;32: 77-82.
86. Gorter JA, Titulaer M, Bos NPA, Huisman E. Chronic neonatal MK-801 administration leads to a long-lasting increase in seizure sensitivity during the early stages of hippocampal kindling. Neurosci Lett 1991;134:29-32.
87. Facchinetti F, Ciani E, Dall'Olio R, Virgili M, Contestabile A, Fonnum F. Structural, neurochemical and behavioral consequences of neonatal blockade of the NMDA receptor through chronic treatment with GCP39551 or MK-801. Dev Brain Res 1993;74:219-24.
88. Kinsman SL, Wilson MA, Johnston MV. MK-801 treatment increases NMDA receptor subunit mRNA expression in rats [Abstract]. Ann Neurol 1994;36:498.
89. Brooks WJ, Petit TL, LeBoutillier JC. Effect of chronic administration of NMDA antagonists on synaptic development. Synapse 1997;26:104-13.